Dilute Coat Alopecia in Dogs: 2025 Update

Color Dilution Alopecia (CDA), also known as color mutant alopecia, is a canine genodermatosis characterized by progressive hair loss specifically affecting diluted pigment areas of the coat. Although considered relatively uncommon in the overall canine population, it represents the most commonly diagnosed inherited dermatosis in dogs. Its recognition and thorough understanding are fundamental for the veterinary dermatologist. They not only enable a definitive diagnosis and differentiation from other alopecic conditions but also provide informed and accurate advice to concerned owners and breeders. The disease manifests as a degradation of coat quality, progressing to often extensive alopecia, and may be accompanied by secondary skin lesions, particularly bacterial infections.

The complexity of CDA lies not only in its clinical manifestations but also in its terminology and its relationship with other follicular dysplasias. Historically, various terms have been used, and its distinction from Black Hair Follicular Dysplasia (BHFD) has been debated. BHFD, which selectively affects black coat areas in white-parti-colored dogs, exhibits notable histopathological similarities with CDA. This relatedness suggests a common pathogenetic basis, where a primary anomaly of pigmentation and follicular structure would be central. This terminological and classificatory nuance reflects the evolution of knowledge and underscores the importance of a rigorous diagnostic approach to these genetically determined dermatological conditions.

2. Etiopathogenesis of CDA

The etiopathogenesis of color dilution alopecia is multifactorial, involving specific genetic bases, complex pathophysiological mechanisms at the hair follicle and pigmentation level, as well as factors modulating its clinical expression.

2.1. Genetic Basis: The MLPH Gene and its Variants

The genetic foundation of CDA is predominantly based on mutations within the melanophilin (MLPH) gene. This gene plays a crucial role in encoding a protein essential for the transport and distribution of melanosomes, pigment-containing organelles, within melanocytes and to surrounding keratinocytes. The dilution of coat color, a phenotypic prerequisite for the development of CDA, is a direct consequence of these mutations.

Several recessive allelic variants (‘d’) of the MLPH gene have been identified as responsible for this dilution phenotype. The most extensively studied and frequently implicated variant is a single nucleotide polymorphism (SNP) located at position c.-22 relative to the translation initiation site in exon 1 of the MLPH gene, consisting of a guanine (G) to adenine (A) substitution (c.-22G>A). Studies have confirmed a close association between this SNP and the dilute coat phenotype in numerous canine breeds. In addition to this main variant (often referred to as d1), other mutations within the MLPH gene have been described, notably the d2 variant, a c.705G>C substitution identified in the Chow-Chow, and the d3 variant, a c.667_668insC insertion reported in the Chihuahua. For a dog to phenotypically express a diluted coat color, and thus be predisposed to CDA, it must be homozygous for one of these recessive alleles (d/d genotype).

CDA is recognized as an autosomal recessive inherited disease. This mode of inheritance implies that both parents of an affected animal must be, at minimum, heterozygous carriers of the mutated allele (D/d) or be affected themselves (d/d).

2.2. Pathophysiological Mechanisms

Mutations in the MLPH gene induce a cascade of cellular and tissue events leading to the clinical manifestations of CDA.

Disruption of melanosome transport and aggregation: The primary functional consequence of MLPH mutations is a defect in the melanosome transport mechanism. This results in an anarchic accumulation and aggregation of these pigment organelles, forming voluminous inclusions called macromelanosomes, within the melanocytes of the epidermis and hair follicles, as well as in the keratinocytes of forming hair shafts. The d/d variant of MLPH is directly responsible for this defect in homogeneous melanosome dispersal, leading to their aggregation. The presence of these macromelanosomes constitutes a distinctive histopathological and trichoscopic feature of CDA.

Follicular dysplasia and alteration of hair structure: The intracytoplasmic accumulation of these macromelanosomes, coupled with possible cytotoxicity exerted by melanin precursors or abnormal melanosomes themselves on hair matrix cells, is considered a major factor in the development of follicular dysplasia. Hair follicles then become structurally abnormal, exhibiting distortions, progressive atrophy, and disruptions of the hair cycle. Simultaneously, the very structure of the hair shafts is compromised. The disordered integration of macromelanosomes into the hair cortex and medulla alters its biomechanical integrity, making it abnormally fragile, brittle, and prone to premature fractures. This hair fragility is a direct contributor to the observed alopecia.

Keratinization anomalies: Keratinization disorders frequently accompany CDA. Hyperkeratosis, particularly at the follicular level, is a common observation, manifesting as the formation of keratin plugs obstructing the hair infundibula. Excessive skin surface desquamation (scales) is also often reported. These keratinization abnormalities contribute to the dry, rough appearance of the skin and can promote infectious complications.

2.3. Genetic Complexity and Factors Influencing Expression

A fundamental and perplexing aspect of CDA is that the presence of an MLPH d/d genotype, although necessary, is not consistently sufficient to induce the alopecic phenotype. Indeed, not all recessive homozygous dogs for dilution variants develop CDA, or they develop it with varying severity and age of onset. This phenomenon, known as incomplete penetrance, strongly suggests the involvement of other genetic factors (modifier genes) or environmental factors in the clinical expression of the disease. For example, it is well established that genetic tests for MLPH variants identify the coat dilution status but cannot predict whether a dilute-colored dog will actually develop CDA. The incidence of CDA in dilute-colored Dobermans is very high, but does not reach 100%, while in other breeds such as the Italian Greyhound, it is significantly lower despite the presence of dilute coats. Even more strikingly, some breeds such as the Weimaraner or Great Dane, which can have dilute coats (and thus a d/d genotype), rarely, if ever, show clinical signs of CDA.

The existence of modifier genes is therefore a predominant hypothesis to explain this inter- and intra-breed variability. Genes such as RAB27A and MYO5A, which encode proteins that functionally interact with melanophilin within the melanosome transport complex, have been logically suggested as potential candidates. However, their direct and specific role in modulating the severity of CDA in d/d dogs has not yet been formally demonstrated by targeted studies. Research has indicated that the risk of developing CDA or BHFD appears to be breed-specific, which strengthens the idea that the overall genetic background of each breed plays a determining modulating role. The precise identification of these modifying factors, whether genetic or environmental, remains an active and crucial field of research. The older hypothesis of a ‘dl’ allele at the D locus, recessive to ‘d’ and directly responsible for alopecia, is less emphasized in recent publications, which are leaning more towards the interaction between MLPH and distinct modifier genes.

This evolution in understanding, from a strict monogenic model to a polygenic or multifactorial model, has considerable implications. In terms of genetic counseling, this means that an MLPH test alone, although informative about dilution status, is insufficient to predict with certainty the risk of developing alopecia. For research, this highlights the need for more comprehensive approaches, such as genome-wide association studies (GWAS) or whole-genome sequencing in cohorts of affected and unaffected d/d dogs, to identify these elusive modifier genes. Ultimately, the characterization of these factors could not only refine the prognosis but also pave the way for new preventive or therapeutic strategies, should these modulators prove to be accessible targets. The identification of these elements could explain why certain lineages or breeds are more vulnerable than others, even when sharing the same MLPH d/d genotype.

3. Epidemiological Aspects

Studying the distribution and determinants of CDA within canine populations provides valuable information for its recognition and management.

3.1. Prevalence and Incidence

Color dilution alopecia is generally considered a relatively uncommon condition when considering the entire canine population. Nevertheless, within the group of genodermatoses, it stands out for a higher frequency of diagnosis, positioning it as the most commonly identified hereditary skin disease in dogs. Precise epidemiological data concerning its prevalence or incidence in large and diverse canine populations remain limited. However, the scientific literature, rich in individual case studies and reports of clinical case series, attests to its presence in a wide range of canine breeds and in various geographical regions around the world.

3.2. Predisposed Breeds

Marked breed predisposition is a salient epidemiological characteristic of CDA. It primarily affects breeds in which diluted pigment coats – such as blue (black dilution), fawn or Isabella (brown/chocolate dilution), or lilac – are not only recognized by breed standards but sometimes actively sought after by breeders and owners. The following table summarizes information on the breeds most frequently reported as being predisposed to CDA.

Table 1: Breeds Predisposed to Color Dilution Alopecia (CDA) and Frequency

Breed	Diluted Colors Affected	Reported Frequency of CDA (if available)
Doberman Pinscher	Blue, Fawn (Isabella)	Very high: 57.9% to 93% in blues; 75% to 89.5% in fawns.
Dachshund	Blue, Isabella	Frequently reported.
Yorkshire Terrier	Blue (on blue and tan coat)	Frequently reported, affecting blue areas of the coat.
Miniature Pinscher	Blue, Fawn	Reported.
Whippet	Blue, Fawn	Frequently reported.
Italian Greyhound	Blue, Fawn	Reported; incidence appears lower than in Dobermans despite the frequency of dilute coats.
Chow Chow	Blue	Reported.
Weimaraner	Mouse Gray (Isabella)	Genetically d/d, but clinical CDA is rarely observed, strongly suggesting the action of protective modifier genes.
Great Dane	Blue	Similar situation to Weimaraner; blue coats exist, but clinical CDA is infrequent.
Labrador Retriever	Charcoal (Blue), Silver (Lilac)	CDA is increasingly recognized in these non-standard dilution colors.
French Bulldog	Blue	CDA is reported in blue individuals.
American Staffordshire Terrier	Blue	Recognized predisposition.
Other Breeds	Various Diluted Colors	Standard Poodle (blue), Irish Setter (fawn), Saluki, Bernese Mountain Dog, Chihuahua, Shetland Sheepdog, Boston Terrier, Newfoundland, Schipperke, Beauceron, German Shepherd, Gascogne Blue.
Mixed Breeds	Diluted coats of various origins	CDA is not exclusive to purebred dogs and has been diagnosed in mixed-breed dogs with a dilute coat.

This list is not exhaustive, but it illustrates the wide distribution of CDA predisposition among canine breeds. The variability of clinical expression, even within predisposed breeds and for the same MLPH d/d genotype (as in the case of the Weimaraner), is a strong argument in favor of the influence of modifying genetic factors or yet poorly characterized environmental factors.

Severe color dilution alopecia in a Yorkshire

3.3. Influence of Age and Sex

The age of onset of the first clinical signs of CDA is variable, but generally falls within a window of 4 months to 3 years. Cases have been reported with symptom onset as early as 3 months of age, and more rarely, in older animals, a case having been described in a 10-year-old dog. This wide range of onset age, including within the same breed, could reflect the heterogeneity of modifying factors influencing disease expression, or the interaction with yet unidentified environmental triggers. If the pathogenesis was solely determined by the MLPH d/d genotype, a narrower onset window might be expected, unless gene expression is subject to intrinsically variable developmental regulation. Thus, this temporal variability, like incomplete penetrance, suggests an etiological complexity where additional genetic, epigenetic, or environmental factors (such as follicular stress related to grooming, nutrition, or general hormonal status) could interact with the primary genetic predisposition to modulate the timing of clinical manifestation.

Regarding the influence of sex, the majority of studies and clinical observations do not report significant sexual predisposition for CDA. Males and females appear to be affected with comparable frequency, which is consistent with the autosomal recessive mode of inheritance of the disease, independent of sex chromosomes.

4. Clinical Manifestations

The clinical manifestations of color dilution alopecia are progressive and characteristic, affecting the quality and density of the coat as well as the integrity of the underlying skin.

4.1. Age of Onset and Evolution

Typically, puppies destined to develop CDA are born with a coat of normal appearance in the diluted color areas. The first signs of the disease manifest insidiously and progressively, most often between the ages of 4 months and 3 years, although variations exist as mentioned previously. Alopecia is characterized by its slow progression, often extending over several months to several years. It can evolve to almost total hair loss in the trunk regions exhibiting diluted pigmentation.

4.2. Description of Hair and Skin Lesions

Coat quality: The first clinical indicator is frequently an alteration in the quality of the coat in diluted color areas. The hair loses its luster, becoming dull, dry, and brittle. Affected hairs may have a “moth-eaten” appearance or diffuse thinning, leading to hypotrichosis. The remaining hair shafts are often rough to the touch and easily fractured by minimal trauma such as rubbing or brushing.

Alopecia: The initial hypotrichosis inexorably evolves into more marked alopecia, the extent and symmetry of which may vary. The first affected areas are classically localized on the trunk, particularly along the dorsal line. Alopecia can then extend to the flanks and abdominal region. Characteristically, the head, limbs, and tail are often spared or are only affected late in the disease’s progression. A pathognomonic sign, in the presence of a dilute coat, is the strict sparing of non-diluted color areas. For example, in a blue and tan Doberman Pinscher, the tan markings will not be affected by alopecia.

Primary and secondary skin lesions: In addition to hair loss, various skin lesions may be observed:

Follicular papules and pustules are frequently encountered. These can evolve into the formation of comedones (blackheads), resulting from the obstruction of hair follicles.
Desquamation, appearing as fine (pityriasiform) or larger (furfuraceous) scales, is a common manifestation, indicative of keratinization disorders.
Secondary bacterial pyoderma is a very frequent and clinically significant complication. It generally manifests as folliculitis or furunculosis, most often caused by the proliferation of Staphylococcus pseudintermedius. This bacterial superinfection is often the primary cause of pruritus in dogs with CDA.
Hypomelanotic macules, i.e., areas of skin with depigmentation, may appear, particularly on the ventral abdomen.
Pruritus (itching) is typically absent or minimal in the absence of infectious complications. When present, it is almost systematically attributable to secondary bacterial pyoderma.

Mottled appearance of color dilution alopecia in a Doberman

The sequence of appearance of these lesions is an important element for diagnostic orientation. Initial coat quality changes, followed by progressive hypotrichosis and then alopecia, generally precede the development of skin complications such as pyoderma. This chronology, combined with the characteristic distribution of lesions (trunk primarily affected, non-diluted areas spared), is highly suggestive of CDA in a dog with a dilute coat. This helps differentiate CDA from other dermatological conditions whose onset would be more abrupt or whose inflammatory signs would be primary.

5. Diagnostic Approach

The diagnosis of color dilution alopecia relies on a methodical approach integrating anamnesis data, clinical signs, and the results of specific complementary examinations, notably trichogram and histopathological examination of skin biopsies.

5.1. Anamnesis and Clinical Examination

A detailed anamnesis is the first crucial step. It should aim to collect precise information regarding the dog’s breed, coat color (and confirmation of the presence of pigment dilution), the exact age of onset of the first dermatological signs, the nature and chronology of lesion evolution, as well as any family history (presence of other affected dogs in the same lineage or litter). Previous treatments and the observed response should also be documented.

The general and dermatological clinical examination must be exhaustive. It will confirm the presence of a dilute coat (blue, fawn, Isabella, etc.) and allow precise characterization of the nature, distribution, and severity of alopecic lesions, as well as the possible presence of primary or secondary skin lesions (papules, pustules, comedones, scales, erythema, crusts, hypomelanotic macules), in accordance with the descriptions provided in the previous section. The evaluation of the extent of alopecia and the search for signs of secondary pyoderma are particularly important.

5.2. Contribution of Trichogram

Microscopic examination of hair (trichogram) is a non-invasive, simple to perform, rapid, and highly informative diagnostic tool in suspected CDA. Hairs are collected by gentle traction from alopecic areas or at the periphery of lesions, mounted between a slide and coverslip in mineral oil or lactophenol, and observed under an optical microscope.

Typical observations in CDA include:

The presence of numerous and voluminous melanin aggregates, or macromelanosomes, of irregular shape and size, anarchically distributed within the cortex and medulla of the hair shafts. These macromelanosomes are the microscopic hallmark of pigment distribution anomaly.
These pigment accumulations can lead to significant distortion of the hair shaft architecture, making it irregular, and causing points of fragility leading to transversal or oblique hair fractures.
Other structural abnormalities of the hairs may be visualized, such as deformed, twisted hair shafts, showing abnormal angulations, or a damaged or absent cuticle in places, particularly at the macromelanosome concentration areas.

5.3. Skin Biopsy and Key Histopathological Features

Skin biopsy, followed by histopathological examination by an experienced veterinary pathologist, is often the examination of choice to confirm the diagnosis of CDA, particularly in atypical cases or to rule out other dermatoses. It is recommended to perform several biopsies (6 or 8 mm punch) on representative alopecic areas, including primary lesions such as follicular papules if possible, as well as an apparently healthy skin area for comparative purposes.

Histopathological features considered typical and diagnostic of CDA are summarized in Table 2.

Table 2: Main Histopathological Characteristics of Color Dilution Alopecia (CDA)

Histopathological Feature	Preferential Location	Detailed Description	Diagnostic Importance
Melanin Aggregates (Macromelanosomes)	Epidermis (basal layer), Follicular epithelium (sheaths, matrix), Hair shafts, Dermis (melanophages)	Large granules or blocks of melanic pigment, irregular in shape and size, often massive.	Very high; almost pathognomonic sign in compatible clinical context.
Follicular Hyperkeratosis	Infundibulum of hair follicles	Thickening of the stratum corneum within the follicle, leading to the formation of lamellar keratin plugs that dilate the follicular opening.	High; contributes to comedones and folliculitis.
Follicular Dysplasia	Hair follicles (entire structure)	Irregularly shaped, twisted, distorted, sometimes atrophic, cystic, or “witch’s foot” appearing follicles. Numerous follicles in telogen phase.	High; reflects abnormal development and function of the follicle.
Pigmentary Incontinence / Dermal Melanophages	Dermis (mainly peribulbar and perifollicular)	Presence of free melanic pigment in the dermis and/or macrophages (melanophages) having phagocytosed this pigment, following its release by damaged epidermal or follicular cells.	Moderate to high; indicates pigmentary remodeling.
Epidermal Hyperkeratosis	Interfollicular epidermis	Thickening of the stratum corneum of the epidermis, often orthokeratotic type.	Moderate; contributes to the scaly appearance of the skin.
Follicular Atrophy	Hair follicles	Reduction in the size of hair follicles, particularly in advanced stages.	Moderate; consequence of chronic dysplasia.
Inflammatory Infiltrate	Follicular, Perifollicular, Dermal	In the absence of superinfection, the infiltrate is generally minimal to mild, lymphoplasmacytic. In case of secondary pyoderma, a neutrophilic (suppurative) or pyogranulomatous (in case of furunculosis) infiltrate will be observed.	Variable; depends on the presence of complications.

The combination of these lesions, particularly the presence of macromelanosomes in the context of follicular dysplasia and hyperkeratosis in a dilute-coated dog, is highly suggestive of the CDA diagnosis.

5.4. Differential Diagnosis

It is imperative to differentiate CDA from other canine dermatological conditions that may manifest as alopecia, whether localized or generalized. Table 3 presents the main differential diagnoses and the criteria for distinguishing them from CDA.

Table 3: Differential Diagnosis of Color Dilution Alopecia (CDA) and Distinctive Criteria

Condition	Key Clinical Signs (besides alopecia)	Typical Trichogram Results	Typical Histopathology Results	Specific Complementary Tests
Color Dilution Alopecia (CDA)	Diluted coat, progressive truncal alopecia, scales, follicular papules/pustules, frequent secondary pyoderma, pruritus if infection. Sparing of non-diluted areas.	Macromelanosomes, deformed/fractured hair shafts.	Follicular hyperkeratosis, macromelanosomes (epidermis, follicles, hairs), follicular dysplasia, dermal melanophages.	Anamnesis, clinical, trichogram, biopsy. MLPH genetic test (predisposition).
Hypothyroidism	Symmetric, non-pruritic alopecia (unless pyoderma), dull, dry coat, thickened skin (myxedema), lethargy, weight gain.	Hairs predominantly in telogen, no macromelanosomes.	Follicular atrophy, epidermal and follicular hyperkeratosis, dermal mucinosis. Absence of macromelanosomes.	Total T4, TSH, free T4 (by equilibrium dialysis).
Hyperadrenocorticism (Cushing’s Syndrome)	Bilateral symmetric truncal alopecia, thin, atrophic skin, comedones, cutaneous calcinosis, abdominal distension, polyuria-polydipsia.	Hairs predominantly in telogen, no macromelanosomes.	Epidermal, dermal, and follicular atrophy, follicular hyperkeratosis, comedones, calcium deposits (calcinosis). Absence of macromelanosomes.	Low-dose dexamethasone suppression test, ACTH stimulation test, urinary cortisol/creatinine ratio.
Black Hair Follicular Dysplasia (BHFD)	Alopecia affecting only black coat areas in white-parti-colored dogs. Early onset.	Similar to CDA but only on black hairs: macromelanosomes, structural abnormalities.	Almost identical to CDA: macromelanosomes in black areas, follicular dysplasia.	Clinical (lesion distribution), trichogram, biopsy.
Alopecia X (Nordic Breed Follicular Dysplasia)	Progressive symmetrical alopecia (trunk, neck, thighs), cutaneous hyperpigmentation. Predisposed breeds (Pomeranian, Husky, Malamute).	“Flame” hairs (catagen/telogen), no macromelanosomes.	Follicular atrophy, infundibular hyperkeratosis, trichilemmal keratinization. Absence of macromelanosomes.	Exclusion of endocrinopathies, biopsy. Sometimes responds to castration or melatonin.
Generalized Demodicosis	Multifocal to generalized alopecia, erythema, scales, comedones, papules, pustules, variable pruritus.	Visualization of Demodex canis (adults, larvae, eggs).	Suppurative or granulomatous folliculitis/perifolliculitis with presence of Demodex in follicles.	Deep skin scrapings, trichogram, (biopsy if scrapings negative and high suspicion).
Dermatophytosis	Circular alopecic, scaly lesions, sometimes crusty, variable pruritus. Can be generalized.	Fungal spores and/or hyphae on or in hair shafts (direct examination with KOH or lactophenol).	Folliculitis/perifolliculitis, perivascular dermatitis. Visualization of fungal elements with special stains (PAS, Grocott).	Wood’s lamp examination (fluorescence for certain strains of Microsporum canis), fungal culture on Sabouraud medium or DTM.

5.5. Genetic Tests

Molecular genetic tests are commercially available to identify the different variants (‘d’ alleles, including d1, d2, d3) of the MLPH gene that are responsible for coat color dilution. These tests allow determination of whether a dog has the recessive homozygous genotype (d/d) necessary to express a dilute coat and, consequently, to be genetically predisposed to CDA.

However, it is crucial to emphasize that, while these tests confirm the dilution status of an animal, they cannot predict with absolute certainty whether a dog carrying the d/d genotype will actually develop clinical signs of alopecia. This limitation is directly related to the phenomenon of incomplete penetrance of CDA and the probable influence of modifying genes or environmental factors, as discussed in section 2.3.

Nevertheless, these genetic tests are of considerable importance for breeding programs. They allow identification of heterozygous dogs (D/d), which have a non-dilute coat phenotype (unless other dilution genes are present) but can transmit the ‘d’ allele to their offspring. By avoiding matings between two carrier dogs (D/d x D/d) or between a carrier and a d/d individual, breeders can significantly reduce, or even eliminate, the risk of producing d/d puppies susceptible to developing CDA.

The diagnostic approach for CDA is therefore an integrative process that cannot rely on a single examination. It combines rigorous analysis of signalment and clinical signs, trichogram results, and the conclusions of histopathological examination. The genetic test for the MLPH gene is part of this approach as a valuable tool to confirm genetic predisposition to dilution and to guide breeding advice. However, the diagnosis of clinical disease, i.e., the expression of alopecia, remains dependent on the confrontation of all clinical and paraclinical data. The future identification of more specific biomarkers or genetic tests targeting CDA modifier genes would constitute a major diagnostic and prognostic advance.

6. Therapeutic Management and Prognosis

The management of color dilution alopecia is primarily symptomatic, given the absence of a curative treatment for this genetically inherited condition.

6.1. General Principles of Management

As of today, there is no treatment capable of correcting the underlying genetic defect of CDA or restoring normal follicular structure and function in diluted coat areas. Structural abnormalities of hair follicles and hair shafts induced by the pigment defect are considered permanent.

Consequently, the therapeutic management of CDA aims for several objectives:

Manage associated skin symptoms, such as dryness, scaling, and pruritus (if present).
Improve, as far as possible, the quality of the skin and remaining coat.
Actively prevent and effectively treat secondary skin infections, particularly bacterial pyoderma.
Maintain a good quality of life for the affected dog.

6.2. Symptomatic Treatments

Topical treatments: Regular use of appropriate topical products is the cornerstone of CDA management.

Keratomodulating and emollient shampoos: These shampoos are used to control the keratoseborrheic condition (scaling, excess sebum or dryness) and to maintain adequate hydration of the skin and coat. Active ingredients such as benzoyl peroxide can be useful for their degreasing, antibacterial, and comedolytic action, especially in the presence of folliculitis or comedones. Other agents such as sulfur, salicylic acid, or various moisturizing and emollient agents (urea, glycerol, colloidal oatmeal, vegetable oils) may also be beneficial depending on the specific clinical picture.
Antiseptic shampoos: The use of shampoos containing antiseptic agents, such as chlorhexidine (at concentrations of 2% to 4%), is essential for long-term management and prevention of secondary bacterial pyoderma, which is a frequent complication. The frequency of antiseptic baths should be adapted to the severity of infections and can vary from once to several times a week during the acute phase, then spaced out during the maintenance phase.

Management of bacterial superinfections: In cases of confirmed bacterial pyoderma (folliculitis, furunculosis), especially if it is deep, extensive, or recurrent, systemic antibiotic therapy is often indispensable. First-line antibiotics, such as cephalexin or the amoxicillin-clavulanic acid combination, are generally prescribed for a duration of 3 to 6 weeks, or at least one week after clinical resolution of lesions. In cases of chronic or refractory infections, it is strongly recommended to perform a bacterial culture with antibiogram from intact pustule samples or skin biopsies, in order to guide the choice of the most appropriate antibiotic and limit the development of bacterial resistance.

SI VOUS ETES VETERINAIRE : Pour lire la suite de cet article, veuillez vous enregistrer en haut à droite. Merci

6.4. Long-Term Prognosis

The vital prognosis for dogs with color dilution alopecia is excellent. CDA is a purely dermatological condition that does not affect the animal’s life expectancy or its general health, apart from its skin manifestations.

However, the prognosis regarding hair regrowth is guarded to poor. Alopecia is generally progressive and tends to become permanent in dilute-colored areas. Significant and lasting hair regrowth is rarely observed, even with various symptomatic or adjuvant therapeutic approaches.

6.5. Long-Term Complications

The long-term complications of CDA are primarily dermatological in nature:

Recurrent bacterial pyoderma: Due to follicular dysplasia, keratinization disorders, and compromised skin barrier, dogs with CDA are highly susceptible to recurrent bacterial skin infections (folliculitis, furunculosis). These infections may require repeated antimicrobial treatments, or continuous long-term topical antiseptic management to limit their frequency and severity.
Increased risk of cutaneous neoplasias: Although robust epidemiological data are still lacking, it has been suggested that chronic loss of hair protection and increased exposure of the skin to ultraviolet (UV) radiation could increase the risk of developing skin tumors, particularly squamous cell carcinoma. A case of squamous cell carcinoma developing on alopecic areas of a dog with CDA has been reported in the literature. As a precautionary measure, sun protection (avoiding prolonged exposure during peak sunlight hours, using protective clothing or dog-specific sunscreens) may be advised for animals with extensive alopecia.

6.6. Advice to Breeders and Prevention

Given the hereditary nature of CDA, with autosomal recessive transmission clearly linked to variants of the MLPH gene, prevention through rigorous selective breeding is the most effective strategy to reduce the incidence of this condition.

It is formally recommended to exclude from breeding dogs affected by CDA (i.e., those with an MLPH d/d genotype and manifesting clinical signs of alopecia).
Parents (sire and dam) of a puppy affected with CDA are obligatorily carriers of the ‘d’ allele (either heterozygous D/d, or affected d/d themselves). Siblings of an affected dog also have a high probability of being carriers or affected and should be genetically tested before any breeding.
The use of genetic tests for the D locus (MLPH) is a valuable tool that allows identification of heterozygous carrier dogs (D/d). These dogs do not have a dilute coat (and therefore no CDA), but can transmit the ‘d’ allele to their offspring. By avoiding matings between two carrier dogs (D/d x D/d), or between a carrier and a d/d individual, breeders can prevent the birth of d/d homozygous puppies, which would then be susceptible to developing CDA.
The situation is complicated, however, by the incomplete penetrance of CDA. Some dogs with a d/d genotype may not develop clinical signs of alopecia (or only very subtle signs) and may still be used for breeding. If they are bred with other d/d dogs or D/d carriers, they can transmit the predisposition to CDA, especially if potential “protective” modifier genes are not also transmitted or if the environmental conditions of their offspring differ. An optimal selection strategy should therefore ideally combine genotyping for the MLPH gene with rigorous phenotypic evaluation (absence of clinical CDA in dilute-colored dogs selected for breeding and in their close relatives).

Long-term management of CDA represents a significant commitment for the owner, involving regular skin care and constant vigilance regarding potential complications. For breeders, prevention through informed genetic selection is paramount. The existence of breeds like the Weimaraner, which are predominantly d/d but rarely develop CDA, represents a particularly interesting research avenue. Identifying the “protective” genetic factors present in these breeds could, eventually, not only refine selection strategies but also potentially open new perspectives for the prevention or modulation of CDA expression in more susceptible breeds.

7. Conclusion

Color dilution alopecia (CDA) is a canine genodermatosis whose understanding has significantly progressed with the identification of the central role of the MLPH gene in coat color dilution and predisposition to alopecia. Nevertheless, the considerable variability of its clinical expression, characterized by incomplete penetrance, highlights the probable involvement of other genetic modifying factors or environmental factors that remain, for the most part, to be elucidated. This etiological complexity represents a challenge for both diagnosis and genetic counseling.

The diagnosis of CDA relies on a rigorous multimodal approach, integrating anamnesis (breed, coat color, history), characteristic clinical signs (progressive alopecia on diluted areas, changes in coat quality, secondary skin lesions), microscopic observations from trichogram (presence of macromelanosomes), and typical histopathological lesions (follicular dysplasia, melanin aggregates, follicular hyperkeratosis). Genetic tests for MLPH variants confirm the predisposition linked to dilution but do not predict the onset of alopecia.

In the absence of a curative treatment, CDA management is primarily symptomatic. It aims to improve the dog’s skin comfort, control keratinization disorders, and prevent or treat infectious complications, mainly recurrent bacterial pyoderma. Adjuvant therapies such as melatonin, essential fatty acids, or retinoids have shown limited or unconfirmed efficacy for hair regrowth in this condition.

Prevention, through responsible breeding strategies including genetic screening of breeding animals for MLPH dilution alleles and phenotypic selection, is crucial to reduce the incidence of CDA in predisposed breeds.

Future research perspectives should focus on the identification and characterization of modifier genes and environmental factors involved in CDA expression. A better understanding of these elements would allow for a refinement of risk assessment for developing alopecia in d/d genotype dogs and, potentially, open new avenues for targeted preventive approaches or innovative therapeutic interventions aimed at modulating the expression of this complex genodermatosis.

8. Bibliographical References

Kim JH, Kang KI, Sohn HJ, Woo GH, Jean YH, Hwang EK. Color-dilution alopecia in dogs. J Vet Sci. 2005 Sep;6(3):259-61.
Perego R, Proverbio D, Roccabianca P, Spada E. Color dilution alopecia in a blue Doberman pinscher crossbreed. Can Vet J. 2009 May;50(5):511-4.
Welle M, Philipp U, Rüfenacht S, Roosje P, Scharfenstein M, Schütz E, Brenig B, Linek M, Mecklenburg L, Grest P, Drögemüller M, Haase B, Leeb T, Drögemüller C. MLPH genotype-melanin phenotype correlation in dilute dogs. J Hered. 2009;100 Suppl 1:S75-9.
Lederer R, Dias JFLG, Kagueyama FM, Schmidt MJ, de Oliveira SVA, Pfeifer M, de Castro VSP, Leal MLR. Identification of SNV c.-22G > A in the melanophilin gene in dogs with color dilution alopecia in Brazil. J Vet Diagn Invest. 2021 Nov;33(6):1195-1199.
Miller WH Jr. Colour dilution alopecia in Doberman pinschers with blue or fawn coat colours: a study on the incidence and histopathology of this disorder. Vet Dermatol. 1990;1(3):113-122.
Dias JFLG, Leal MLR, de Castro VSP, et al. Identification of SNP c.-22G>A in the melanophilin gene from a dog with color dilution alopecia. Arq Bras Med Vet Zootec. 2018;70(4):1055-1060.
Palumbo MIPC, Salzo PS, Giocondo CBS, et al. Carcinoma de células escamosas em um cão com alopecia por diluição de cor. Vet Zootec. 2012;19:507–512.
Cerqueira A, Laranjo M, Ferreira A, Alexandre N, Rema A, Nunes T. Color dilution alopecia in a Yorkshire terrier. Braz J Vet Pathol. 2022;15(3):80-84.
Drögemüller C, Philipp U, Haase B, Günzel-Apel AR, Leeb T. A noncoding melanophilin gene (MLPH) SNP at the splice donor of exon 1 represents a candidate causal mutation for coat color dilution in dogs. J Hered. 2007 Sep-Oct;98(5):468-73.
Bauer A, Kehl A, Jagannathan V, Leeb T. A novel MLPH variant in dogs with coat colour dilution. Anim Genet. 2018 Feb;49(1):94-97.
Van Buren SL, Minor KM, Grahn RA, Mickelson JR, Grahn JC, Malvick J, Colangelo JR, Hytönen MK, Lohi H, KGUOF. A third MLPH variant causing coat color dilution in dogs. Genes (Basel). 2020 Jun 9;11(6):639.
Schmutz SM, Moker JS, Clark EG, Shewfelt R. Black hair follicular dysplasia, an autosomal recessive condition in dogs. Can Vet J. 1998 Oct;39(10):644-6.
Brancalion L, Haase B, Wade CM. Canine coat pigmentation genetics: a review. Anim Genet. 2022 Feb;53(1):3-34.